Develops stem cell treatments for orthopedic issues and autoimmune diseases.
Dec 2025Revenue $701K/yrExpenses $1.07M/yr
No trendCash runway ≈ 8 months from Jun 2026
Figures by year
When will Adia Med be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $701K and expenses $1.07M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $701K | $1.07M | −$366K |
| Dec 2024 | $6.38K | $181K | −$175K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.